Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
No new human infections with A/H5N1 in Turkey but national measures and international support continue.
Networking of Public Health Microbiology Laboratories Bolsters Europe's Defenses against Infectious Diseases
Albiger, B., Revez, J., Leitmeyer, K.C., Struelens, M.J.
Protective measures for humans against avian influenza a(H5N8) outbreaks in 22 European Union/European economic area countries and Israel, 2016–17
Adlhoch, C., Dabrera, G., Penttinen, P., Pebody, R.
Estimation of the number of exposed people during highly pathogenic avian influenza virus outbreaks in EU/EEA countries, October 2016–September 2018
Adlhoch, C., Miteva, A., Zdravkova, A., Miškić, T., Kneževic, D., Perdikaris, S., Śmietanka, K., Świętoń, E., Kopriva, V., Chudý, M., Romero González, L.J., Moreno Gil, I., Wallén Norell, A., Verdonck, F.